SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001136261-22-000221
Filing Date
2022-05-12
Accepted
2022-05-12 08:30:23
Documents
2

Document Format Files

Seq Description Document Type Size
1 424(B)(5) seel424b5.htm 424B5 552247
2 GRAPHIC image4190.jpg GRAPHIC 3218
  Complete submission text file 0001136261-22-000221.txt   557988
Mailing Address 300 PARK AVENUE 2ND FLOOR NEW YORK NY 10022
Business Address 300 PARK AVENUE 2ND FLOOR NEW YORK NY 10022 (646) 293-2100
SEELOS THERAPEUTICS, INC. (Filer) CIK: 0001017491 (see all company filings)

IRS No.: 870449967 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-251356 | Film No.: 22915833
SIC: 2834 Pharmaceutical Preparations